GlassScriptPhysician profile
Torin W Rutner
NPI 1285707273
$3,597.43
in general payments reported to CMS, 2019-2025
11 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $587 · 2021: $91.75 · 2022: $554 · 2023: $654 · 2024: $852 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357 · Education: $300 · Entertainment: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.71 |
| Education | $300.00 |
| Entertainment | $200.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,307.64 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,011.91 | 2019-2021 | |
| Keystone Dental INC. | $471.68 | 2022-2023 | |
| Abbvie INC. | $363.66 | 2023-2025 | Botox |
| Nobel Biocare USA | $155.39 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $129.33 | 2019-2025 | Biomaterials, Bio-Gide |
| Straumann USA LLC | $95.64 | 2020-2025 | |
| Pacira Pharmaceuticals Incorporated | $17.77 | 2019 | |
| Biolase, INC. | $16.60 | 2019 | |
| Integra Lifesciences Corporation | $16.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torin Rutner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.